A multicenter, randomized, placebo-controlled phase IIb trial of an autologous formalin-fixed tumor vaccine for newly diagnosed glioblastomas.
Muragaki Y, Ishikawa E, Maruyama T, Nitta M, Saito T, Ikuta S, Komori T, Kawamata T, Yamamoto T, Tsuboi K, Matsumura A, Nakamura H, Kuroda J, Abe T, Momii Y, Saito R, Tominaga T, Tabei Y, Suzuki I, Arakawa Y, Miyamoto S, Matsutani M, Karasawa K, Nakazato Y, Maebayashi K, Hashimoto K, Ohno T.
Muragaki Y, et al. Among authors: komori t.
J Neurosurg. 2023 Jan 20;139(2):344-354. doi: 10.3171/2022.12.JNS221221. Print 2023 Aug 1.
J Neurosurg. 2023.
PMID: 36670529
Clinical Trial.